CRIS earnings date and last-quarter result: last quarter beat, P/E -0.21. Updated 2026-07-23.
Curis (CRIS) Research Hub
Curis (CRIS) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.3773 USD (-2.33%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.21, market cap 0.01B. This hub links to the full technical, earnings and options research available for CRIS.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.3773 USD (-2.33%) |
| 52-week range | 0.325 USD – 11.4 USD |
| Trend regime | Range |
| 14-day RSI | 7.1 (Oversold) |
| Trailing P/E | -0.21 |
| Market cap | 0.01B |
| Dividend yield | 0.00% |
Available research for CRIS
Covered Call on CRIS: how it works, illustrative setup around the real 0.3773 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CRIS: how it works, illustrative setup around the real 0.3773 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CRIS: how it works, illustrative setup around the real 0.3773 USD price, max profit/loss, breakeven and when to use it. Educational.
CRIS technical analysis: range, last 0.3773 USD, RSI 7.1, 52w range 0.325 USD–11.4 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is CRIS in?
Curis (CRIS) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is CRIS in an uptrend or downtrend?
As of 2026-10-26, CRIS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CRIS's trailing P/E ratio?
CRIS's trailing P/E is -0.21, with a market cap of 0.01B. See the earnings research page for full valuation detail.